Pacific Biosciences of California, Inc. (PACB)
1.315
+0.04
(+2.73%)
USD |
NASDAQ |
Sep 02, 16:00
1.315
0.00 (0.00%)
After-Hours: 17:53
Pacific Biosciences of California Research and Development Expense (Annual) : 95.21M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 95.21M |
| December 31, 2024 | 129.02M |
| December 31, 2023 | 187.17M |
| December 31, 2022 | 193.00M |
| December 31, 2021 | 112.90M |
| December 31, 2020 | 64.15M |
| December 31, 2019 | 59.63M |
| December 31, 2018 | 62.59M |
| December 31, 2017 | 65.32M |
| December 31, 2016 | 67.62M |
| Date | Value |
|---|---|
| December 31, 2015 | 60.44M |
| December 31, 2014 | 48.23M |
| December 31, 2013 | 45.22M |
| December 31, 2012 | 47.62M |
| December 31, 2011 | 72.58M |
| December 31, 2010 | 111.82M |
| December 31, 2009 | 73.56M |
| December 31, 2008 | 36.81M |
| December 31, 2007 | 18.82M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Illumina, Inc. | 951.00M |
| Danaher Corp. | 1.598B |
| Agilent Technologies, Inc. | 450.00M |
| Bio-Rad Laboratories, Inc. | 257.60M |
| Thermo Fisher Scientific, Inc. | 1.397B |